Harvard University: Timeline of key events

Mouseover the event title for a more detailed description of the event (if available). To search for particular terms in the description of the event enter the term in the box below 'Event' on the table and press 'enter'. Alternatively use the dropdown lists to filter by Person, Place or Science. Click here to clear the filter.

C Doyle, JL Strominger, 'Interaction between CD4 and class II MHC molecules mediates cell adhesion', Nature, 330 (1987), 256-9.1987-11-19T00:00:00+0000USPTO patent 4,736,866, transgenic mouse with activated oncogenes created by Philip Leder and Timonthy A Stewart. The mouse was developed as a model for furthering cancer research and the testing of new drugs. It was the first animal ever given patent protection in the USA. 1988-04-12T00:00:00+0000CE Rudd, JM Trevillyan, JD Dasgupta, LL Wong, SF Schlossman, 'The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (Pp58) from human T lymphocytes', Proc Natl Acad Sci USA, 85 (1988), 5190-94.1988-07-01T00:00:00+0000Bloch shared the 1964 Nobel Prize for Medicine for 'discoveries concerning the mechanism and regulation of the cholesterol and fatty acid metabolism.'2000-10-15T00:00:00+0000Scientists at Harvard Stem Cell Institute report fusing adult skin cells with embryonic stem cells to reset the culture so that the cells behave like embryonic stem cells.2005-08-25T00:00:00+0000A Ventura, et al, 'Restoration of p53 function leads to tumour regression in vivo', Nature, 445 (2007), 661-5; W Xue, et al, 'Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas', Nature, 445 (2007), 656–60.2007-01-01T00:00:00+0000Scientists at the Harvard Stem Cell Institute report the creation of stem cells for 10 genetic disorders that will enable researchers to watch diseases develop in a lab dish. The researchers used ordinary skin cells and bone marrow from people with a variety of diseases, including Parkinson's, Huntington's and Down syndrome to produce the stem cells.2008-08-08T00:00:00+0000Zhang, F, Cong, L, Lodato, Kosuri, S, Church, G, Arlotta, P, 'Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription', Nature Biotechnology, 29 (2011), 149–53. 2011-01-19T00:00:00+0000Benacerraf shared the Nobel Prize for Medicine in 1980 for 'discoveries concerning genetically determined structures on the cell surface that regulates immunological reactions'.2011-08-02T00:00:00+0000Osborn, M J, Starker, C G, McElroy, A N, 'TALEN-based gene correction for epidermyolysis bullosa', Molecular Therapy, 21/6 (2013), 1151-9.2013-06-01T00:00:00+0000Work presented by geneticist George Church of Harvard Medical School to US National Academy of Sciences.2015-10-05T00:00:00+0000J E DiCarlo, A Chavez, S L Dietz, K M Esvelt, G M Church, 'Safeguarding CRISPR-Cas9 gene drives in yeast', Nature Biotechnology, doi:10.1038/nbt.3412.2015-11-16T00:00:00+0000Nelson, C E, Hakim, C H, Ousterout, D G, Thakore, P I, et al, 'In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy', Science, DOI: 10.1126/science.aad51432015-12-31T00:00:00+0000Kleinstiver, B P, Pattanayak, V, Prew, M S, Tsai, S Q, Nguyen, N T, Zheng, Z, Joung, K, 'High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects', Nature, doi:10.1038.2016-01-06T00:00:00+0000Based on the analysis of data from hundreds of patients, scientists found markers on tumour cells flagging up very early mutations of the disease. The advantage is these appear on all tumour cells, thereby providing a good target for treatment. N. McGranahan, et al, 'Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade', Science, 351/6280 (2016), 1463-69. 2016-03-25T00:00:00+0000LD Landegger et al, 'A synthetic AAV vector enables safe and efficient gene transfer to the mammalian inner ear', Nature Biotechnology, 6 Feb 2017, doi:10.1038/nbt.37812017-02-06T00:00:00+0000J. S. Gootenberg, O.O. Abudayyeh, J. W. Lee, et al, 'Nucleic acid detection with CRISPR-Cas13a/C2c2', Science, 13 April 2017, eaam9321, DOI: 10.1126/science.aam9321 2017-04-13T00:00:00+0000
Date Event People Places Sciences
Nov 1987First evidence provided for the interaction between the surface molecule CD4 and major histocompatibility class IIDoyle, StromingerHarvard UniversityImmunology, Cancer immunotherapy, Oncology
Apr 1988OncoMouse patent grantedLeder, StewartHarvard UniversityTransgenic animals
Jul 1988Biochemical initiators of T Cell activitation, CD4 and CD8-p56, discoveredRudd, Trevillyan, Dasupta, Wong, SchlossmanDana-Faber Cancer Institute, Harvard University, Tech UniversityImmunology, Cancer immunotherapy, Oncology
15 Oct 2000Konrad Bloch diedBlochHarvard UniversityBiochemistry
Aug 2005Adult skin cells reprogrammed to be like embryonic stem cellsCowan, Eggen, Melton, AtienzaHarvardStem cells
2007p53-induced senescence shown to prevent cancerVentura, Kirsch, McLaughlin, Tuveson, Grimm, Lintault, Newman, Reczek, Weissleder, Jacks, Xue, Zender, Miething, Dickins, Hernando, Krizhanovsky, Cordon-Cardo, LoweMassachusetts Institute of Technology, Massachusetts General Hospital, Harvard University, Howard Hughes Medical Institute, Cold Spring Harbor LaboratoryOncology, p53
Aug 2008Scientists create stem cells for 10 disorders Harvard Stem Cell InstituteStem cells
19 Jan 2011US scientists publish a technique for genetically engineering transcription activator-like effectors customised to recognise specific DNA-binding sites which they show is an effective tool for editing mammalian genomesZhang, Cong, Lodato, Kosuri, Church, ArlottaHarvard University, Massachusetts Institute of Technology Gene editing, TALENs
2 Aug 2011Baruj Benacerraf diedBenacerrafHarvard Medical SchoolImmunology
1 Jun 2013Basic studies conducted with TALENs to see if can correct mutant genes associated with Epidermolysis Bullosa, a rare inherited skin disorderOsborn, Starker, Colby, McElroyUniversity of Minnesota, National Centre for Tumor Diseases Heidelberg, German Cancer Research Centre, Harvard UniversityGene Therapy, Gene editing, TALENs
5 Oct 2015US Scientists report use of CRISPR to modify 60 genes in pig embryos in first step to create pig organs suitable for use in humansChurchHarvard UniversityCRISPR-Cas9, Gene editing, Transgenic animals
16 Nov 2015US Scientists publish a technique for overwriting changes made by CRISPR/Cas 9DiCarlo, Chavez, Dietz, Esvelt, ChurchHarvard University, Swiss Federal Institute of Technology in Zurich CRISPR-Cas9, Gene editing
31 Dec 2015CRISPR successfully used to improve muscle function in mouse model of Duchenne muscular dystrophy, opening way to use CRISPR to correct genetic mutatiuons in affected tissues of sick patientsNelson, Gersbach, Hakim, Ousterout, ThakoreDuke University, University of Missouri, University of North Carolina, Massachusetts Institute of Technology, Harvard UniversityCRISPR-Cas9, Gene editing, Gene therapy
6 Jan 2016Harvard scientists published improved version of CRISPR/Cas 9 with less risk of off-target DNA breaksKleinstiver, Pattanayak, Prew, Tsai, Nguyen, Zheng, JoungHarvard UniversityCRISPR-Cas9, Gene editing
25 Mar 2016Common tags discovered on the surface of cancer cells opening up new avenues for immunotherapyMcGranahan, Furness, Rosenthal, Ramskov, Lyngaa, Saini, Jamal-Hanjani, Wilson, Birkbak, Hiley, Watkins, Shafi, Murugaesu, Mitter, Akarca, Linares, Marafioti, Henry, Van Allen, Miao, Schilling, Schadendorf, Garraway, Makarov, Rizvi,m Snyder, Hellman, MerghUniversity College London, Cancer Research UK, Francis Crick Insitute, Dana-Farber Cancer Institute, Broad Institute, University Duisburg-Essen, Memorial Sloan Kettering Cancer Center, Columbia Univertsity, Weill Cornell Medical College, Harvard Medical SImmunology, Cancer immunotherapy, Oncology
6 Feb 2017Gene therapy shown to restore hearing in deaf miceLandegger, Pan, Askew, Wassmer, Gluck, Galvin, Taylor, Forge, Sankovic, Holt, VandenbergheEaton Peabody Laboratories, Harvard Medical School, Medical University of Vienna, UCL, Boston's Children's Hospital, Harvard Stem Cell Institute, University of North Carolina, Grousbeck Gene Therapy CenterGene therapy
13 Apr 2017CRISPR shown to be sensitive diagnostic tool for detecting single target of DNA or RNA moleculeAbudayyeh, Bhattacharyya, Collins, Daringe, Donghia, Dy, Essletzbichler, Freije, Hung, Joung, Koonin, Lee, Livny, Myhrvold, Regev, Sabeti, Gootenberg, Verdine, ZhangBroad Institute, Massachusetts Institute of Technology, Harvard University, Howard Hughes Medical Institute CRISPR-Cas9, Gene editing

Nov 1987

First evidence provided for the interaction between the surface molecule CD4 and major histocompatibility class II

Apr 1988

OncoMouse patent granted

Jul 1988

Biochemical initiators of T Cell activitation, CD4 and CD8-p56, discovered

15 Oct 2000

Konrad Bloch died

Aug 2005

Adult skin cells reprogrammed to be like embryonic stem cells

2007

p53-induced senescence shown to prevent cancer

Aug 2008

Scientists create stem cells for 10 disorders

19 Jan 2011

US scientists publish a technique for genetically engineering transcription activator-like effectors customised to recognise specific DNA-binding sites which they show is an effective tool for editing mammalian genomes

2 Aug 2011

Baruj Benacerraf died

1 Jun 2013

Basic studies conducted with TALENs to see if can correct mutant genes associated with Epidermolysis Bullosa, a rare inherited skin disorder

5 Oct 2015

US Scientists report use of CRISPR to modify 60 genes in pig embryos in first step to create pig organs suitable for use in humans

16 Nov 2015

US Scientists publish a technique for overwriting changes made by CRISPR/Cas 9

31 Dec 2015

CRISPR successfully used to improve muscle function in mouse model of Duchenne muscular dystrophy, opening way to use CRISPR to correct genetic mutatiuons in affected tissues of sick patients

6 Jan 2016

Harvard scientists published improved version of CRISPR/Cas 9 with less risk of off-target DNA breaks

25 Mar 2016

Common tags discovered on the surface of cancer cells opening up new avenues for immunotherapy

6 Feb 2017

Gene therapy shown to restore hearing in deaf mice

13 Apr 2017

CRISPR shown to be sensitive diagnostic tool for detecting single target of DNA or RNA molecule